United Kingdom - 25 Nov 2025: University of Cambridge spin-out BioTryp Therapeutics has joined forces with Montreal-based preclinical drug discovery research company, Intellisyn Pharma, to accelerate the development of next-generation treatments for recurrent bacterial infections. The two organisations have secured major bi-national support, including advisory services and funding of up
United Kingdom - November 18, 2025: The Innovate UK Sustainable Medicines Manufacturing Innovation Programme (SMMIP) has announced funding for eight pioneering R&D initiatives designed to push forward cleaner, more intelligent, and more sustainable approaches to medicines production. CPI is contributing to five of these projects, which together have
November 10, 2025: Convatec has announced plans to expand its research and development (R&D) presence in the United Kingdom with a £500 million investment over the next decade. The move is part of the company’s broader global strategy to accelerate innovation in chronic care solutions. As part
London, UK – 05 November 2025: British biotechnology company Cizzle Biotechnology Holdings plc (LSE: CIZ) has taken a major step toward transforming lung cancer diagnosis in the UK. The company has signed a Letter of Intent (LOI) with a leading UK-based clinical laboratory provider to introduce its CIZ1B blood test, a
United Kingdom, 03 Nov 2025: A new artificial intelligence tool designed to support prostate cancer diagnosis and treatment planning will soon be trialled across NHS hospitals, scientists have revealed. The initiative, known as the £1.9 million Vanguard Path study, is funded by Prostate Cancer UK and led by experts